Condition
Pancreatic Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 15 Pancreatic Carcinoma clinical trials that are recruiting, at sites in 16 countries (most in United States (10), China (6), Japan (2)). By phase: Phase 2 (2), Phase 1/2 (2), Phase 3 (1), Phase 1 (1). There are also 1 NIH-funded research project on Pancreatic Carcinoma, with $218,467 in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 15Clinical trials
- 1NIH research projects
- 16Countries
Newest Pancreatic Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Laryngopharyngeal injuries after breathing tube placement during general anesthesia | — | Hangzhou, Zhejiang and 1 other locations | Recruiting | Jan 22, 2026 |
| In-home cancer treatment with remote specialist support for patients in the Florida Panhandle | Phase 2 | Jacksonville, Florida | Recruiting | Dec 16, 2025 |
| Dual-target CAR-T therapy targeting mesothelin and CLDN18.2 for advanced pancreatic cancer | Phase 1/2 | Beijing, Beijing Municipality | Recruiting | Jul 15, 2025 |
| Vanguard: a new blood test approach to screen for multiple cancers | — | Pleasanton, California and 45 other locations | Recruiting | May 30, 2025 |
| Lanreotide versus placebo before surgery to prevent a pancreatic fistula | Phase 3 | Birmingham, Alabama and 117 other locations | Recruiting | Feb 4, 2025 |
| Testing XNW28012 in patients with advanced solid tumors who have not responded to standard treatments | Phase 1/2 | Hefei, Anhui and 23 other locations | Recruiting | Jan 29, 2025 |
| Testing MGC028 in patients with advanced solid tumors | Phase 1 | San Francisco, California and 6 other locations | Recruiting | Dec 9, 2024 |
| Early detection of pancreatic cancer using exosome-based biomarkers | — | Phoenix, Arizona and 12 other locations | Recruiting | Apr 29, 2024 |
| Detecting pancreatic cancer in high-risk individuals | — | Scottsdale, Arizona and 10 other locations | Recruiting | Feb 21, 2024 |
| Investigating HER3-DXd for advanced solid tumors | Phase 2 | Duarte, California and 95 other locations | Recruiting | Dec 15, 2023 |
All recruiting trials (15)
-
Laryngopharyngeal injuries after breathing tube placement during general anesthesia
This project sees how often and why people who had a breathing tube during general anesthesia developed hoarseness or other throat problems after non-ear–nose–throat surgery.
-
In-home cancer treatment with remote specialist support for patients in the Florida Panhandle
This program will try giving standard cancer treatments at home to people living in the Florida Panhandle and nearby areas to see if they prefer it and have better treatment satisfaction.
-
Dual-target CAR-T therapy targeting mesothelin and CLDN18.2 for advanced pancreatic cancer
This treatment will try sequential CAR‑T cell infusions that target mesothelin and CLDN18.2 in people with unresectable or metastatic pancreatic adenocarcinoma who have received prior systemic therapy.
-
Vanguard: a new blood test approach to screen for multiple cancers
This study will test two different blood-based multi-cancer detection tests in adults 45–75 without cancer to see if they find cancers earlier than usual care.
-
Lanreotide versus placebo before surgery to prevent a pancreatic fistula
This trial will see if giving lanreotide before a planned distal pancreatectomy lowers the risk of a pancreatic fistula in adults with pancreatic cancer or a suspicious pancreatic lesion.
-
Testing XNW28012 in patients with advanced solid tumors who have not responded to standard treatments
This study is testing a new treatment called XNW28012 in patients with advanced solid tumors who haven't had success with regular cancer therapies to see if it can help them.
-
Testing MGC028 in patients with advanced solid tumors
This study is testing a new treatment called MGC028 to see if it is safe and can help adults with advanced solid tumors that can't be removed or have spread.
-
Early detection of pancreatic cancer using exosome-based biomarkers
This study is testing a new way to find pancreatic cancer early by looking at tiny particles in the blood that carry specific markers.
-
Detecting pancreatic cancer in high-risk individuals
This study is trying to find better ways to detect pancreatic cancer early in people who are at high risk due to family history or genetic factors.
-
Investigating HER3-DXd for advanced solid tumors
This study is testing a new drug called HER3-DXd to see if it can safely help people with advanced solid tumors like melanoma, head and neck cancer, and gastric cancer who have already tried other treatments.
-
Using indocyanine green to predict leaks after pancreas surgery
This study is testing if a special dye given during pancreas surgery can help doctors predict if patients will have leaks after the operation.
-
Comparing blood samples from cancer-draining veins to standard veins in patients with liver and pancreatic cancers
This study is testing if taking blood samples from veins near liver and pancreatic tumors can help find cancer DNA better than using regular veins in patients getting biopsies.
-
Comparing two surgical methods for pancreatic cancer treatment
This study is testing if a less invasive surgery for pancreatic cancer works better than traditional surgery in helping patients live longer after treatment.
-
Comparing minimally invasive and open surgery for pancreatic cancer
This study is testing whether a less invasive surgery for pancreatic cancer can be safer and more effective than the traditional open surgery for patients.
-
High-resolution imaging to detect micrometer-scale cancer in pancreatic tissue
This study tests ultra-high resolution optical coherence tomography (OCT) to see if it can spot tiny cancer cells in pancreatic tissue from people having pancreatic surgery for IPMN or pancreatic cancer.
NIH-funded research (1)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Light-activated therapy to boost immunotherapy in pancreatic cancer
This approach uses a light-activated drug placed into pancreatic tumors to trigger an immune response so immunotherapy medicines may work better for people with pancreatic cancer.
Related topics
Quick answers
How many Pancreatic Carcinoma clinical trials are recruiting right now?
15, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 16 countries. The most sites are in United States (10 trials), China (6 trials), Japan (2 trials), South Korea (2 trials), Australia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1/2: 2, Phase 3: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.